Evidence map›Paper›PMID 23754279›Full record

ArticleThe Journal of biological chemistry2013

The MOV10 helicase inhibits LINE-1 mobility.

Xiaoyu Li, Jianyong Zhang, Rui Jia, Vicky Cheng, Xin Xu, Wentao Qiao, Fei Guo, Chen Liang, Shan Cen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. BeyondInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Evolutionary and Expression Analysis ofInternational journal of molecular sciences · 2022
    Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Xiaoyu LiFrom the Institute of Medicinal Biotechnology and.
Jianyong Zhangthe Lady Davis Institute-Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada,; the Departments of Medicine and.
Rui JiaNankai University, Tianjin 300071, China.
Vicky Chengthe Lady Davis Institute-Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada,; Microbiology and Immunology, McGill University, Montreal, Quebec H3A 2B4, Canada, and.
Xin XuNankai University, Tianjin 300071, China; the Institute of Pathogen Biology, Chinese Academy of Medical Science, Beijing 100050, China.
Wentao QiaoNankai University, Tianjin 300071, China.
Fei Guothe Institute of Pathogen Biology, Chinese Academy of Medical Science, Beijing 100050, China.
Chen LiangFrom the Institute of Medicinal Biotechnology and; the Departments of Medicine and; Microbiology and Immunology, McGill University, Montreal, Quebec H3A 2B4, Canada, and. Electronic address: chen.liang@mcgill.ca.
Shan CenFrom the Institute of Medicinal Biotechnology and. Electronic address: shancen@imb.pumc.edu.cn.
Institute of Medicinal Plant Development · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNNankai University · CNJewish General Hospital · CAMcGill University · CA

Funding

Canadian Institutes of Health Research 2012CB911102
6 · The paper itself

Abstract

LINE-1 (long interspersed element 1) is an autonomous non-long terminal repeat retrotransposon. Its replication often causes mutation and rearrangement of host genomic DNA. Accordingly, host cells have evolved mechanisms to control LINE-1 mobility. Here, we report that a helicase named MOV10 effectively suppresses LINE-1 transposition. Mutating the helicase motifs impairs this function of MOV10, suggesting that MOV10 requires its helicase activity to suppress LINE-1 replication. Further studies show that MOV10 post-transcriptionally diminishes the level of LINE-1 RNA. The association of MOV10 with both LINE-1 RNA and ORF1 suggests that MOV10 interacts with LINE-1 RNP and consequently causes its RNA degradation. These data demonstrate collectively that MOV10 contributes to the cellular control of LINE-1 replication.

Indexed as

5' Untranslated RegionsAnimalsArgonaute ProteinsDNA, ComplementaryGene Knockdown TechniquesHEK293 CellsHeLa CellsHumansLong Interspersed Nucleotide ElementsMicePromoter Regions, GeneticRNARNA HelicasesRNA Stability5' Untranslated RegionsAGO2 protein, humanArgonaute ProteinsDNA, ComplementaryMov10 protein, humanRNARNA HelicasesHost-Pathogen InteractionsLINE-1MOV10Post-transcriptionalRestrictionRetrotransposonReverse TranscriptionRNA HelicaseViral ReplicationVirology

Identifiers

PMID23754279
PMCPMC3774381
OpenAlexW1977771685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.